Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Grade

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Oncotarget|September 28, 2014
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancerJochen Gaedcke, Andreas Leha, Rainer Claus, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
United European Gastroenterology Journal|September 16, 2025
Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal CancerJonas Buchloh, Melanie Spitzner, Hauke Zimmermann, et al.
Cancers|February 3, 2021
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to ChemoradiotherapyKristin Koerdel, Melanie Spitzner, Thomas Meyer, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Clinical Epigenetics|June 21, 2019
ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cellsMadhobi Sen, Xin Wang, Feda H Hamdan, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast DifferentiationTareq Hossan, Sankari Nagarajan, Simon J Baumgart, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Scientific Reports|October 19, 2016
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor BiopsiesPeter Jo, Manuel Nietert, Linda Gusky, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Oncotarget|September 28, 2014
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancerJochen Gaedcke, Andreas Leha, Rainer Claus, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
United European Gastroenterology Journal|September 16, 2025
Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal CancerJonas Buchloh, Melanie Spitzner, Hauke Zimmermann, et al.
Cancers|February 3, 2021
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to ChemoradiotherapyKristin Koerdel, Melanie Spitzner, Thomas Meyer, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Clinical Epigenetics|June 21, 2019
ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cellsMadhobi Sen, Xin Wang, Feda H Hamdan, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast DifferentiationTareq Hossan, Sankari Nagarajan, Simon J Baumgart, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
Scientific Reports|October 19, 2016
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor BiopsiesPeter Jo, Manuel Nietert, Linda Gusky, et al.
Pageof 9